
    
      Open-label active treatment Phase III study of Pennsaid (diclofenac sodium 1.5% topical
      solution) to determine the effects on coagulation parameters in patients who are equal to or
      greater than 55 years of age with moderate to severe osteoarthritis knee pain and who are
      also taking warfarin, dabigatran, or aspirin and/or clopidogrel.
    
  